Afsana Sheikh
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 13
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery 5
- Molecular Medicine top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 7
- Molecular Biology top 10%
- RNA Interference and Gene Delivery 19
- Advanced biosensing and bioanalysis techniques 9
-
- Dendrimers and Hyperbranched Polymers 6
-
- Immunotherapy and Immune Responses 5
-
- Wound Healing and Treatments 2
- Co-authors
- Prashant KesharwaniMohammed A. S. AbourehabShadab MdMahak FatimaVirendra GajbhiyeRajesh SalveAmirhossein SahebkarNazeer Hasan
- Journals
- Journal of Controlled Release (1 paper)International Journal of Pharmaceutics (5 papers)Molecular Cancer (5 papers)
- Partner nations
- IndiaSaudi ArabiaIran
In The Last Decade
Afsana Sheikh
43 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Biomaterials 701
- Pharmaceutical Science 265
- Molecular Medicine 90
- Biomedical Engineering 667
- Molecular Biology 798
Countries citing papers authored by Afsana Sheikh
This map shows the geographic impact of Afsana Sheikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afsana Sheikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afsana Sheikh more than expected).
Fields of papers citing papers by Afsana Sheikh
This network shows the impact of papers produced by Afsana Sheikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afsana Sheikh. The network helps show where Afsana Sheikh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Afsana Sheikh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 18 | |
| 2 | 2023 | 47 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 12 | |
| 5 | 2023 | 39 | |
| 6 | 2023 | 37 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 26 | |
| 10 | 2023 | 27 | |
| 11 | 2023 | 12 | |
| 12 | 2023 | 29 | |
| 13 | 2022 | 35 | |
| 14 | 2022 | 26 | |
| 15 | 2022 | 37 | |
| 16 | 2022 | 17 | |
| 17 | 2022 | 38 | |
| 18 | 2022 | 29 | |
| 19 | 2021 | 54 | |
| 20 | 2021 | 25 |
About Afsana Sheikh
Afsana Sheikh is a scholar working on Biomaterials, Pharmaceutical Science and Polymers and Plastics, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (19 papers), Nanoparticle-Based Drug Delivery (13 papers), Advanced biosensing and bioanalysis techniques (9 papers), Nanoplatforms for cancer theranostics (7 papers), Dendrimers and Hyperbranched Polymers (6 papers), Immunotherapy and Immune Responses (5 papers), Advancements in Transdermal Drug Delivery (5 papers) and Wound Healing and Treatments (2 papers). The work is most often cited by research in Biomaterials (701 citations), Pharmaceutical Science (265 citations) and Molecular Medicine (90 citations). Afsana Sheikh has collaborated with scholars based in India, Saudi Arabia and Iran. Frequent co-authors include Prashant Kesharwani, Mohammed A. S. Abourehab, Shadab Md, Mahak Fatima, Virendra Gajbhiye, Rajesh Salve, Amirhossein Sahebkar, Nazeer Hasan, Neelima Gupta and Waleed Y. Rizg. Their work appears in journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.